CLINICAL_TRIALS
trial_result
· 2026-02-19
Clinical Trial Update: DAY101 In Gliomas and Other Tumors [Phase 1]
Summary
A Phase 1 trial update for DAY101 in gliomas and other tumors, with the Low-grade glioma arm reported as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Karen D. Wright, MD | Conditions: Low-grade Glioma | Phase 1 | Status: COMPLETED